I've gathered historical Daily Dab spreadsheets from AB and have pulled comparisons over time to see where FITX has performed relative to the rest of the companies related to MJ.
From April 9th through today, FITX PPS performance ranks #12 out of 63 companies that were traded over this time, with a loss of 33%. Only 4 companies have actually appreciated in PPS. The average result - a loss of 55%. Almost 1/3 of the companies have lost 70% or more. That is the sector performance my friends and an overwhelming majority of those companies aren't handcuffed waiting for a government license to get their business rolling.
Losing money is not easy for anyone and a 33% drop is not easy to swallow. I've been on board since the end of Feb and have picked up more shares on various dips along the way (including today) to bring my average down, but I'm still significantly in the red.
All of us have our limits and human nature is to be driven by fear and greed to a certain extent, though it's disappointing to see the erosion on this board over the last week. I'm not here to drink the kool-aid, but to see the name calling and all is banter for IHUB, not here. I'd like to think that we're better than that.
I'm not interested in what Matt F has to say about 2013, nor do I feel the need to get a statement out of BC to calm my nerves. I expect BC and the BOD to be focused on what it takes to capture market share and expand the business quickly once we receive the license. With HC not issuing any licenses in the recent months, this tells me that they have other issues than simply too much work - something is going on behind the scenes to either rethink the process and how to ensure there are no more initial launch issues with newly licensed companies, or the MMAR/MMPR legal issues are presenting government delays. It's not the responsibility of CEN-BIO to provide updates on the license - they've done everything they can do through the application and are waiting (im)patiently. I would expect that they are maintaining an arm's length relationship with HC to understand the expected timing of inspection.
FITX made the announcement that they brought on Delloitte on June 19th. I understand that it takes time to schedule auditors, perform the audit and issue results, but I'd like to see some results on this within the next month, along with Q2 results with Hemp Tech figures now included. This should also tell us where we're at with the private investor funding.
Step back and review why you're here and if the business case and future outlook has changed since when you first bought shares. If it has, then go ahead and reevaluate your position. If it hasn't, then try not to get lost in the day to day PPS swings and keep your eye on the prize.
Regards,
-kbulldog.
From April 9th through today, FITX PPS performance ranks #12 out of 63 companies that were traded over this time, with a loss of 33%. Only 4 companies have actually appreciated in PPS. The average result - a loss of 55%. Almost 1/3 of the companies have lost 70% or more. That is the sector performance my friends and an overwhelming majority of those companies aren't handcuffed waiting for a government license to get their business rolling.
Losing money is not easy for anyone and a 33% drop is not easy to swallow. I've been on board since the end of Feb and have picked up more shares on various dips along the way (including today) to bring my average down, but I'm still significantly in the red.
All of us have our limits and human nature is to be driven by fear and greed to a certain extent, though it's disappointing to see the erosion on this board over the last week. I'm not here to drink the kool-aid, but to see the name calling and all is banter for IHUB, not here. I'd like to think that we're better than that.
I'm not interested in what Matt F has to say about 2013, nor do I feel the need to get a statement out of BC to calm my nerves. I expect BC and the BOD to be focused on what it takes to capture market share and expand the business quickly once we receive the license. With HC not issuing any licenses in the recent months, this tells me that they have other issues than simply too much work - something is going on behind the scenes to either rethink the process and how to ensure there are no more initial launch issues with newly licensed companies, or the MMAR/MMPR legal issues are presenting government delays. It's not the responsibility of CEN-BIO to provide updates on the license - they've done everything they can do through the application and are waiting (im)patiently. I would expect that they are maintaining an arm's length relationship with HC to understand the expected timing of inspection.
FITX made the announcement that they brought on Delloitte on June 19th. I understand that it takes time to schedule auditors, perform the audit and issue results, but I'd like to see some results on this within the next month, along with Q2 results with Hemp Tech figures now included. This should also tell us where we're at with the private investor funding.
Step back and review why you're here and if the business case and future outlook has changed since when you first bought shares. If it has, then go ahead and reevaluate your position. If it hasn't, then try not to get lost in the day to day PPS swings and keep your eye on the prize.
Regards,
-kbulldog.
